“BELIEVE Trial: Using Comprehensive Genomic Profiling to Expand Access to Off-Label Oncology Drugs in Japan”

https://pubmed.ncbi.nlm.nih.gov/38112833

The BELIEVE trial is a platform study in Japan using comprehensive genomic profiling to improve access to off-label oncology drugs for patients with actionable genetic abnormalities, contributing to precision medicine and collaboration between industry and academia.